Protea Biosciences Group, Inc.·4

Feb 13, 9:41 PM ET

Protea Biosciences Group, Inc. 4

4 · Protea Biosciences Group, Inc. · Filed Feb 13, 2014

Insider Transaction Report

Form 4
Period: 2005-12-15
POWELL MATTHEW
Dir. R&D; Chief Science Off.
Transactions
  • Award

    Stock Option

    2005-12-15$40000.00/sh+80,000$3,200,000,00080,000 total
    Exercise: $0.50From: 2005-12-15Exp: 2015-12-15Common Stock (80,000 underlying)
  • Award

    Stock Option

    2007-01-19$125000.00/sh+100,000$12,500,000,000180,000 total
    Exercise: $1.25From: 2007-01-19Exp: 2017-01-19Common Stock (100,000 underlying)
  • Award

    Stock Option

    2009-12-31$60000.00/sh+40,000$2,400,000,000220,000 total
    Exercise: $1.50From: 2009-12-31Exp: 2019-12-31Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]Represents shares vested as of February 10, 2014.

Documents

1 file
  • 4
    v368363_4.xmlPrimary

    OWNERSHIP DOCUMENT